The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
Noncanonical NF-κB Signaling in Health and Disease: Trends in Molecular Medicine
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-k
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
NIK SMI1 | NF-κB Inhibitor | MedChemExpress
Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors - ScienceDirect
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
The structure of Amgen NIK compounds. | Download Scientific Diagram
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
Frontiers | The Therapeutic Potential of Targeting NIK in B Cell Malignancies
A novel inhibitor of NF-κB-inducing kinase prevents bone loss by inhibiting osteoclastic bone resorption in ovariectomized mice - ScienceDirect
Kinase inhibition in autoimmunity and inflammation | Nature Reviews Drug Discovery
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
NIKing BAFF's limelight | Nature Reviews Rheumatology
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
SMAC mimetics promote NIK-dependent inhibition of CD4+ TH17 cell differentiation | Science Signaling
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation - ScienceDirect
Transcreener ADP Assay Enables Evaluation of NIK Inhibitors in Lupus Drug Discovery - BellBrook Labs
